Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis
- PMID: 24852325
- DOI: 10.1016/j.jneuroim.2014.04.017
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis
Abstract
We recently found a gene signature for multiple sclerosis (MS) that reverted to normal during pregnancy in MS patients and included NR4A2 and TNFAIP3, key molecules in anti-inflammatory processes. Here we focus on the expression levels of these two genes in monocytes and CD4+ T cells from healthy controls and treatment-naïve RRMS patients. Our findings show that monocytes play a key role in the dysregulated anti-inflammatory response, being the expression of both genes down-regulated in these cells in RRMS patients with respect to healthy individuals. CD4+ T cells seem to have only a marginal part, because we can observe only a slight down-regulation in NR4A2.
Keywords: CD4+ T cells; Monocytes; Multiple sclerosis; NR4A2; TNFAIP3.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis.Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14. Arch Neurol. 2011. PMID: 21403007
-
Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response.Front Immunol. 2021 Jun 25;12:676644. doi: 10.3389/fimmu.2021.676644. eCollection 2021. Front Immunol. 2021. PMID: 34248958 Free PMC article.
-
Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.Int J Immunogenet. 2015 Apr;42(2):106-10. doi: 10.1111/iji.12183. Epub 2015 Feb 12. Int J Immunogenet. 2015. PMID: 25684197
-
Adenosine Modulates NR4A Orphan Nuclear Receptors To Attenuate Hyperinflammatory Responses in Monocytic Cells.J Immunol. 2015 Aug 15;195(4):1436-48. doi: 10.4049/jimmunol.1402039. Epub 2015 Jul 6. J Immunol. 2015. PMID: 26150530
-
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Trends Immunol. 2009. PMID: 19643665 Review.
Cited by
-
Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity.J Neuroinflammation. 2020 Apr 6;17(1):102. doi: 10.1186/s12974-020-01783-8. J Neuroinflammation. 2020. PMID: 32248814 Free PMC article. Review.
-
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.Brain Pathol. 2021 Mar;31(2):283-296. doi: 10.1111/bpa.12906. Epub 2020 Nov 18. Brain Pathol. 2021. PMID: 33051914 Free PMC article.
-
A potential protective role of the nuclear receptor-related factor 1 (Nurr1) in multiple sclerosis motor cortex: a neuropathological study.Brain Commun. 2023 Mar 17;5(2):fcad072. doi: 10.1093/braincomms/fcad072. eCollection 2023. Brain Commun. 2023. PMID: 37056475 Free PMC article.
-
Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment.BMC Genomics. 2022 May 11;23(Suppl 4):362. doi: 10.1186/s12864-022-08580-y. BMC Genomics. 2022. PMID: 35545758 Free PMC article.
-
Deubiquitinases in muscle physiology and disorders.Biochem Soc Trans. 2024 Jun 26;52(3):1085-1098. doi: 10.1042/BST20230562. Biochem Soc Trans. 2024. PMID: 38716888 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials